Alterity Therapeutics (ATHE) Other Operating Expenses (2015)

Alterity Therapeutics (ATHE) recorded quarterly Other Operating Expenses of -$4.7 million in Q4 2015.

Alterity Therapeutics (ATHE) Other Operating Expenses (2015) Analysis & Trends

Alterity Therapeutics' Other Operating Expenses history runs 1 years deep, the most recent figure standing at -$4.7 million for Q4 2015.

In Q4 2015, Other Operating Expenses changed N/A year-over-year to -$4.7 million; the TTM figure through Jun 2017 stood at -$4.7 million (changed 0.0% YoY), while the FY2014 annual figure was -$1.3 million, changed N/A from the prior year.
Other Operating Expenses was -$4.7 million for Q4 2015 at Alterity Therapeutics.
In the past five years, Other Operating Expenses ranged from a high of -$4.7 million in Q4 2015 to a low of -$4.7 million in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn
9	Abivax	90.15 Bn	90.15 Bn	-
10	Regeneron Pharmaceuticals	63.59 Bn	54.83 Bn	3.31 Bn

Download Data

Date	Value
Dec 31, 2015	-4.74 Mn